Higher, But Cautious | GenomeWeb

Higher, But Cautious

Biotech stocks are climbing high, but Reuters' Deena Beasley writes that a nearly 50 percent increase in the last year has stoked worries about a bubble. She notes that the Nasdaq Biotech Index is up 45 percent as compared to last year and the Pharmaceutical Index is similarly up 32 percent, while during the same timeframe, the S&P 500 Index gained 25 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.